PeptideStack
5.2kquestions
20kanswers
220users

My orforglipron vial sat at 2–8 °C for forty-two days — is testing worth it before use?

Asked 29 Oct 2025Modified 9 months agoViewed 7.6k times
20

What I am working with: orforglipron · 2–8 °C · forty-two days.

I am trying to build something sustainable rather than something thorough that I will abandon.

I have already decided the broad direction; this is about the specifics.

How would you structure this, and what thresholds would you set in advance?

cold-chain
cold-chain

Keeping material within a temperature window from manufacture to use: phase-change packs versus dry ice, thermal mass, transit-lane temperature…

524 questionspeptide-stability
peptide-stability

The chemistry of peptide degradation: deamidation, oxidation, hydrolysis, aggregation and fibrillation, and how temperature, pH, ionic strength,…

832 questionsbatch-testing
batch-testing

Testing at the batch or lot level: sampling plans, how many vials from a lot need testing to say anything about the lot, and the difference…

865 questions
shareeditfollowflag
UM
askedu100_marks38k3829 Oct 2025
This matches what I was told by a laboratory, for whatever that is worth. – amara_nwachukwu 7 months ago
Minor: the trial name is hyphenated in the original publication. – Dr_Ilse_Vandenberg 9 months ago
add a comment

No answers yet

This question has not been answered. It has been viewed 7.6k times, which suggests the question is of interest and the answer is not obvious. If you can answer it with a source or a worked calculation, it will be read. See how to ask and answer.
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.